Newsletter

The Drug Policy Monitor newsletters examine the value of pharmaceutical within America's healthcare system. They focus on issues surrounding drug safety, including importation, counterfeit medicines and government regulations. To receive these newsletters via email, click here.

Encouraging Consumers to Import Foreign Drugs Puts American Patients at Risk

(Drug Policy Monitor Newsletter - June 25, 2007) This issue focuses on drug safety and how strong regulations for drug manufacturing, labelling and distribution help to safeguard the drug supply chain.

DPM - Drug Importation.pdf 28.69 kB